Estimativa de custos evitados atribuídos a um programa de rastreio de colo curto para prevenção da prematuridade na perspectiva do SUS

Autores/as

DOI:

https://doi.org/10.11606/s1518-8787.2023057004376

Palabras clave:

Recém-Nascido Prematuro, Colo do Útero, Programas de Rastreamento

Resumen

OBJETIVO: Realizar uma análise econômica de custo da implementação de um programa de rastreio de colo curto para redução da prematuridade em gestações únicas num horizonte temporal de curto prazo. MÉTODOS: Realizamos uma análise econômica do tipo custo-benefício utilizando o banco de dados do P5 trial, um ensaio clínico multicêntrico randomizado para prevenção da prematuridade. A coleta de dados ocorreu de julho de 2015 a março de 2019 em 17 diferentes hospitais do Brasil. Comparamos os custos do rastreamento universal em mulheres com gestação única de 18 a 22 semanas e 6 dias associado à progesterona vaginal profilática 200 mg/dia até 36 semanas naquelas com colo ≤ 25 mm com os do não rastreamento. O horizonte temporal foi do nascimento até 10 semanas após o parto. O desfecho foi medido monetariamente em real brasileiro (R$) na perspectiva do Sistema Único de Saúde. RESULTADOS: Entre 7.844 mulheres, 6,67% (523) apresentaram colo ≤ 25mm. O custo do rastreio com a ultrassonografia transvaginal mais a progesterona vaginal para prevenção de nascimentos < 34 semanas foi estimado em R$ 383.711,36, enquanto o não rastreamento gerou custo adicional estimado de R$ 446.501,69 (relacionado aos 29 partos prematuros não rastreados). Assim, o rastreamento mais a profilaxia geraria uma redução de custo final de R$ 62.790,33, apresentando-se como uma possível estratégia de custo-benefício. CONCLUSÃO: O rastreamento universal de colo curto para prematuridade apresenta menores custos em relação ao não rastreamento dentro de um horizonte temporal de curto prazo, o que sugere uma interessante relação de custo versus benefício. Novos estudos que considerem a custo-efetividade do tratamento profilático utilizando-se de análises de sensibilidade em diferentes cenários dentro do sistema de saúde brasileiro, assim como análises que considerem os custos de longo prazo atrelados ao nascimento prematuro, são necessários para justificar com robustez a implementação de um programa de rastreamento.

Referencias

Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019 Jan;7(1):e37-46.

https://doi.org/10.1016/S2214-109X(18)30451-0

Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, et al.; National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med. 1996 Feb;334(9):567-72. https://doi.org/10.1056/NEJM199602293340904

Liu CZ, Ho N, Nguyen AD, Lehner C, Sekar R, Amoako AA. The risk of preterm delivery and pregnancy outcomes in women with asymptomatic short cervix: a retrospective cohort study. J Matern Neonatal Med. 2021 Jun;;34(11)1747-53.

https://doi.org/10.1080/14767058.2019.1647163

Souka AP, Papastefanou I, Pilalis A, Kassanos D, Papadopoulos G. Implementation of universal screening for preterm delivery by mid-trimester cervical-length measurement. Ultrasound Obstet Gynecol. 2019 Mar;53(3):396-401. https://doi.org/10.1002/uog.19050

Figo Working Group On Best Practice In Maternal-Fetal Medicine, International Federation of Gynecology and Obstetrics. Best practice in maternal-fetal medicine. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet. 2015 Jan;128(1):80-2. https://doi.org/10.1016/j.ijgo.2014.10.011

Romero R, Conde-Agudelo A, Fonseca E, O’Brien JM, Cetingoz E, Creasy GW, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018 Feb;218(2):161-80. https://doi.org/10.1016/j.ajog.2017.11.576

Stewart LA, Simmonds M, Duley L, Llewellyn A, Sharif S, Walker RA, et al. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. Lancet. 2021 Mar;397(10280):1183-94. https://doi.org/10.1016/S0140-6736(21)00217-8

Society for Maternal-Fetal Medicine Publications Committee, Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol. 2012 May;206(5):376-86. https://doi.org/10.1016/j.ajog.2012.03.010

SMFM Statement: use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth. Am J Obstet Gynecol. 2020 Jul;223(1):B16-8. https://doi.org/10.1016/j.ajog.2020.04.001

Prediction and prevention of spontaneous preterm birth. Prediction and ACOG Practice Bulletin, Number 234. Obstet Gynecol. 2021 Aug;138(2):e65-90. https://doi.org/10.1097/AOG.0000000000004479

Rozenberg P. [Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?] J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1337-45. French. https://doi.org/10.1016/j.jgyn.2016.09.023

Peixoto AB, Caldas TMC, Tahan LA, Petrini CG, Martins WP, Costa FD, et al. Second trimester cervical length measurement for prediction spontaneous preterm birth in an unselected risk population. Obstet Gynecol Sci. 2017 Jul;60(4):329-35. https://doi.org/10.5468/ogs.2017.60.4.329

Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol. 2011 Jul;38(1):1-9. https://doi.org/10.1002/uog.9073

Dean S V, Mason E, Howson CP, Lassi ZS, Imam AM, Bhutta ZA. Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action. Reprod Health. 2013;10 Suppl 1(Suppl 1):S3. https://doi.org/10.1186/1742-4755-10-S1-S3

Passini R Jr, Cecatti JG, Lajos GJ, Tedesco RP, Nomura ML, Dias TZ, et al. Brazilian multicentre study on preterm birth (EMIP): prevalence and factors associated with spontaneous preterm birth. PLoS One. 2014 Oct;9(10):e109069. https://doi.org/10.1371/journal.pone.0109069

Desgualdo CM, Riera R, Zucchi P. Cost estimate of hospital stays for premature newborns in a public tertiary hospital in Brazil. Clinics (São Paulo). 2011;66(10):1773-7. https://doi.org/10.1590/S1807-59322011001000016

Pacagnella RC, Silva T, Cecatti JG, Passini-Jr R, Fanton T, Borovac-Pinheiro A, et al. 2 Pessary plus progesterone to prevent preterm birth in women with a short cervix (P5 trial). Am J Obstet Gynecol. 2021;224(2 Supplement):S1-2. https://doi.org/10.1016/j.ajog.2020.12.104

Conde-Agudelo A, Romero R, Fonseca E, O’Brien JM, Cetingoz E, Creasy GW, et al. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Am J Obstet Gynecol. 2018 Jul;219(1):10-25.

https://doi.org/10.1016/j.ajog.2018.03.028

Agência Nacional de Vigilância Sanitária. Listas de preços de medicamentos. Brasília, DF: Ministério da Saúde; k2021 [citado 8 out 2021]. Disponível em: https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/cmed/precos

Cahill AG, Odibo AO, Caughey AB, Stamilio DM, Hassan SS, Macones GA, et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol. 2010 Jun;202(6):548.e1-8. https://doi.org/10.1016/j.ajog.2009.12.005

Werner EF, Hamel MS, Orzechowski K, Berghella V, Thung SF. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. Am J Obstet Gynecol. 2015 Oct;213(4):554.e1-6. https://doi.org/10.1016/j.ajog.2015.06.020

Conde-Agudelo A, Romero R. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Am J Obstet Gynecol. 2016 Feb;214(2):235-42. https://doi.org/10.1016/j.ajog.2015.09.102

Luu TM, Rehman Mian MO, Nuyt AM. Long-term impact of preterm birth: neurodevelopmental and physical health outcomes. Clin Perinatol. 2017 Jun;44(2):305-14. https://doi.org/10.1016/j.clp.2017.01.003

Jacob J, Lehne M, Mischker A, Klinger N, Zickermann C, Walker J. Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth. Eur J Health Econ. 2017 Nov;18(8):1041-6. https://doi.org/10.1007/s10198-016-0850-x

Kim HJ, Jo MW, Bae SH, Yoon SJ, Lee JY. Measuring the burden of disease due to preterm birth complications in Korea Using Disability-Adjusted Life Years (DALY). Int J Environ Res Public Health. 2019 Feb;16(3):519. https://doi.org/10.3390/ijerph16030519

Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov;392(10159):1859-922.

https://doi.org/10.1016/S0140-6736(18)32335-3

McCurdy RJ, Baxter JK. Universal cervical length screening with a cervicometer to prevent preterm birth <34 weeks: a decision and economic analysis. J Matern neonatal Med. 2020 Nov;33(21):3670-9. https://doi.org/10.1080/14767058.2019.1583202

Crosby DA, Miletin J, Semberova J, Daly S. Is routine transvaginal cervical length measurement cost-effective in a population where the risk of spontaneous preterm birth is low? Acta Obstet Gynecol Scand. 2016 Dec;95(12):1391-5. https://doi.org/10.1111/aogs.13021

Mario DN, Rigo L, Boclin KL, Malvestio LM, Anziliero D, Horta BL, et al. Quality of Prenatal Care in Brazil: National Health Research 2013. Cien Saude Colet. 2019 Mar;24(3):1223-32. https://doi.org/10.1590/1413-81232018243.13122017

The Fetal Medicine Foundation. The FMF certification cervical assessment. London, 2021 [citado 10 jan 2022]. Disponível em: https://fetalmedicine.org/fmf-certification-2/cervical-assessment-1

Silva TV, Bento SF, Katz L, Pacagnella RC. “Preterm birth risk, me?” Women risk perception about premature delivery: a qualitative analysis. BMC Pregnancy Childbirth. 2021 Sep;21(1):633. https://doi.org/10.1186/s12884-021-04068-x

Publicado

2023-11-10

Número

Sección

Original Articles

Cómo citar

Silva, T. V., Borovac-Pinheiro, A., & Pacagnella, R. C. (2023). Estimativa de custos evitados atribuídos a um programa de rastreio de colo curto para prevenção da prematuridade na perspectiva do SUS. Revista De Saúde Pública, 57(1), 87. https://doi.org/10.11606/s1518-8787.2023057004376

Datos de los fondos